Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD. (Q52595727)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19750478%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19750478%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19750478%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19750478%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19750478%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19750478%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19750478%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Niklas Czeloth

1 reference

7 February 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19750478%20AND%20SRC:MED&resulttype=core&format=json

author name string

Anja Bubke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19750478%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Susanne Schmitz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19750478%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Jochen Huehn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19750478%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Arnold Ganser

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19750478%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

English

0 references

publication date

1 November 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19750478%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

7 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19750478%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19750478%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19750478%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

3091-3096

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19750478%20AND%20SRC:MED&resulttype=core&format=json

Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia

7 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

Th2 lymphoproliferative disorder of LatY136F mutant mice unfolds independently of TCR-MHC engagement and is insensitive to the action of Foxp3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021

In vivo-activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021

Clinical application of regulatory T cells for treatment of type 1 diabetes and transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021

Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021

Efficient generation of human alloantigen-specific CD4+ regulatory T cells from naive precursors by CD40-activated B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021

Antigen-induced regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021

CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021

Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021

Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021

All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021

From vanilla to 28 flavors: multiple varieties of T regulatory cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021

Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021

In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021

Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021

The critical contribution of TGF-beta to the induction of Foxp3 expression and regulatory T cell function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021

In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021

CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021

DNA methylation controls Foxp3 gene expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021

Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021

Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939432

7 January 2021